Amplexd Therapeutics focuses on the development of non-invasive, topical treatments aimed at addressing HPV-induced cervical dysplasia, a precursor to cervical cancer. The company's mission centers on providing accessible solutions to combat this public health issue, offering alternatives to the traditional 'watch and wait' approachfor low-grade cases.

4P-Pharma specializes in the development of therapeutics that offer treatment for osteoarthritis with analgesic and anti-inflammatory properties.

Clock.bio aims to extend and improve quality of life by reversing the harmful effects of time in our cells, harnessing the regenerative capabilities of human pluripotent stem cells.

SciTech Development provides pharmaceuticals comprising nanoparticle fenretinide formulation with immunotherapy benefits, as well as a patented nanoparticle delivery technology, allowing physicians to treat their patients with effective and advanced therapies.